Cite
Host-directed therapy of tuberculosis based on interleukin-1 and type I interferon crosstalk.
MLA
Mayer-Barber, Katrin D., et al. “Host-Directed Therapy of Tuberculosis Based on Interleukin-1 and Type I Interferon Crosstalk.” Nature, vol. 511, no. 7507, July 2014, pp. 99–103. EBSCOhost, https://doi.org/10.1038/nature13489.
APA
Mayer-Barber, K. D., Andrade, B. B., Oland, S. D., Amaral, E. P., Barber, D. L., Gonzales, J., Derrick, S. C., Shi, R., Kumar, N. P., Wei, W., Yuan, X., Zhang, G., Cai, Y., Babu, S., Catalfamo, M., Salazar, A. M., Via, L. E., Barry III, C. E., & Sher, A. (2014). Host-directed therapy of tuberculosis based on interleukin-1 and type I interferon crosstalk. Nature, 511(7507), 99–103. https://doi.org/10.1038/nature13489
Chicago
Mayer-Barber, Katrin D., Bruno B. Andrade, Sandra D. Oland, Eduardo P. Amaral, Daniel L. Barber, Jacqueline Gonzales, Steven C. Derrick, et al. 2014. “Host-Directed Therapy of Tuberculosis Based on Interleukin-1 and Type I Interferon Crosstalk.” Nature 511 (7507): 99–103. doi:10.1038/nature13489.